Moon Express wants to win the Google Lunar X Prize, but going to the moon, the company suggests, is unlikely to be “a good business.”
After losing billions trying to make it in the tough Chinese market, the ride-hailing app pioneer is shifting some spending into technology.
New guidelines finally confirm the legal status of Uber and its rivals in China, but it’s unlikely that drivers will be considered full employees.
Sex robots, climate hacking, and the true cost of medicine made our list of taboo technology topics.
Estonia aims to bring 10 million people to its digital shores.
The company may have failed, but not everything it did was a bad idea.
Cardiologist and genomic-medicine expert Eric Topol makes his case for a future of “medical selfies.”
Raising millions, Editas proved that investors are enthusiastic about gene editing. Now the company has to make its technology work.
Thirteen years after the human genome was sequenced, some remarkable treatments are being developed.
Herceptin, the original genetic drug, showed that not all cancers are alike.